Veradermics, Incorporated (MANE)
NYSE · Common stock · Pharmaceutical Preparations
As of Oct 21, 2:18 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow MANE in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on MANE and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
MANE at a glance
Key statistics
$5.31B
Market capitalization
- Previous close
- $127.11
- Open
- $125.93
- Day range
- $125.93 – $138.95
- Volume
- 444.8K
- Average volume (30 sessions)
- 902.5K
- Shares outstanding
- 41.78M
- Beta (1 year, vs SPY)
- 0.96
Where the price sits in its year
52-week range
100% of the range
- Below the 52-week high
- -0.1%
- Above the 52-week low
- +333.6%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day average
- 20-day average
- $117.89+7.8%
- 50-day average
- $109.75+15.8%
- 200-day average
- —
Between the conventional 30 and 70 bands.
+9.3%
1 week
+12.7%
1 month
+15.7%
3 months
—
Year to date
—
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with MANE
MANE on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on MANE.
See the plans →
Every planScreen names like MANE
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on MANE
Put MANE on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on MANE
See whether there is an open premium alert on MANE, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
MANE headlines
No headlines on the wire for MANE in recent weeks.
SEC Form 4, most recent first
Insider filings
Hollander David
+9.7K
Chief R&D Officer · Grant or award
· Sep 1, 2026
Hollander David
+19.3K
Chief R&D Officer · Grant or award
· Sep 1, 2026
Averill Master Fund, Ltd.
−151.0K
Director · Option exercise
· Aug 20, 2026
Averill Madison Master Fund, Ltd.
−690.6K
Director · Open-market sale
$74.07M · Aug 19, 2026
Cowen Aaron
−151.0K
Insider · Option exercise
· Aug 20, 2026
Averill Master Fund, Ltd.
−690.6K
Director · Open-market sale
$74.07M · Aug 19, 2026
MONTANOVA CAPITAL, LLC
+151.0K
Director · Option exercise
· Aug 20, 2026
Averill Master Fund, Ltd.
−59.4K
Director · Open-market sale
$6.37M · Aug 19, 2026
About Veradermics, Incorporated
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
- Exchange
- NYSE
- Security
- Common stock
- Industry
- Pharmaceutical Preparations
- Headquarters
- New Haven, CT
- Employees
- 21
- Listed since
- Feb 4, 2026
- Website
- veradermics.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.